Aptose Biosciences Inc.
8-K
March 19, 2026
Key Highlights
- ISS (Institutional Shareholder Services) has recommended approval of the acquisi...
- Hanmi Pharmaceutical, a major South Korean drug company, is acquiring Aptose Bio...
- The acquisition offers Aptose shareholders C$2.41 in cash per share, representin...
Read Analysis
🤖 AI Generated